Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Capital Stock (Tables)

Capital Stock (Tables)

3 Months Ended

Nov. 30, 2014

Schedule of Capital Stock, Warrants [Table Text Block]

			Weighted Average
	Number of Shares		Exercise Price
Balance, October 31, 2013 and 2012	-	$	-
Granted warrants with expiry date of November 1, 2015	500,000		0.10
Granted warrants with expiry date of September 21, 2015	10,600,000		0.25
Granted warrants with expiry date of April 1, 2015	552,380		0.40
Granted warrants with expiry date of February 12, 2016	1,302,333		0.25
Granted warrants with expiry date of March 26, 2016	305,200		0.25
Balance, November 30, 2014	13,259,913	$	0.25

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details